ArticleJournal of immunology (Baltimore, Md. : 1950)2010

NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.

Nobuyoshi Hanaoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.